Mesenchymal Stem Cells and Cell Therapy for Bone Repair

Area of Science:

• Regenerative Medicine
• Cell-Based Therapies
• Biomedical Research

Background:

• Mesenchymal stem cells (MSCs) possess multipotency, immunomodulation, and cytokine production capabilities.
• MSCs are being explored as a novel therapeutic approach for diverse diseases.
• Extensive clinical research highlights the potential of MSCs in various medical applications.

Purpose of the Study:

• To provide an overview of the current clinical landscape of MSC-based therapies.
• To analyze the status of ongoing and completed clinical trials involving MSCs.
• To specifically highlight the application of MSCs in treating bone defects and injuries.

Main Methods:

• Systematic search of the public clinical trials database (clinicaltrials.gov).
• Analysis of registered clinical trials for Mesenchymal stem cells (MSCs).
• Focus on trials related to the treatment of bone defects and injuries.

Main Results:

• Over 425 clinical trials involving MSCs have been conducted across at least 12 pathological conditions.
• Many completed trials have demonstrated the safety and efficacy of MSC-based treatments.
• MSCs are actively investigated for their role in bone regeneration and repair.

Conclusions:

• Mesenchymal stem cells (MSCs) represent a significant area of clinical research with demonstrated safety and efficacy.
• The therapeutic potential of MSCs is being realized across a wide range of diseases.
• Further research and clinical application of MSCs, especially for bone defects, are warranted.